A. Tarampikou

Prognostic significance of distant metastasis-free interval in patients with relapsed melanoma treated with BRAF with or without MEK inhibitors.

H. Gogas, H. Linardou, D. Bafaloukos, 2019, Melanoma research.

The use of crevicular fluid to assess markers of inflammation and angiogenesis, IL-17 and VEGF, in patients with solid tumors receiving zoledronic acid and/or bevacizumab

I. Papassotiriou, O. Nicolatou‐Galitis, H. Linardou, 2019, Supportive Care in Cancer.